Atlas Trials

Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets

Clinical trial NCT01687920 · COMPLETED

Trial details

NCT number
NCT01687920
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure
Start date
2012-09-17
Primary completion
2012-11-28
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.